A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemotherapy
Status:
Completed
Trial end date:
2007-10-09
Target enrollment:
Participant gender:
Summary
This is a Phase III trial designed to demonstrate that casopitant when added to dexamethasone
and ondansetron is more effective in the prevention of vomiting then dexamethasone and
ondansetron alone, in patients who receive a cisplatin-based highly emetogenic chemotherapy.